Built from 13 videos across 1 channels · 30d meta-analysis
1 sourceCoverage in this window rests on a single channel: TraderTV Live.
Mentions13
Channels1
Videos13
StanceBull · 96%
Dominant convictionMedium
72h momentum-29%
Dominant signalFund.
StageCooling
window30d
BubbleIndex2v1 · YouTube only
Not financial advice — This breakdown shows what YouTube finance creators are saying about OGN — not what the stock will do. Not financial advice.
Conviction breakdown
By signal, stance, and conviction level
By signal type
Fundamental
89%
News event
11%
By stance
Bullish
96%
Neutral
4%
By conviction
Medium
64%
High
32%
Low
4%
The narratives
Top reasoning snippets from creator analysis
The presenter highlights the activation of Origenics' clinical trial and its potential in a market with no current FDA-approved therapies, indicating strong confidence in its prospects.
The presenter discusses Ogen's activation of a clinical trial and its focus on developing a treatment for concussions, indicating a positive outlook on the company's progress and potential.
The presenter discusses Orgenesis's clinical trial progress and financial improvements, indicating a strong belief in the company's future potential based on fundamental developments.
Origenics is discussed in relation to its clinical trials and market potential, indicating a bullish sentiment.
The presenter discusses Orogenics' activation of a clinical trial and improvements in its financial position, indicating a positive outlook for the company.
Conviction history
Daily bull / bear / neutral split from the durable pipeline archive
BullishNeutralBearish
Creator coverage
Channels mentioning OGN this window
First in this window: TraderTV Live · Jun 30, 2026